Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-15-000537
Filing Date
2015-02-13
Accepted
2015-02-13 17:57:17
Documents
1
Period of Report
2015-02-11

Document Format Files

Seq Description Document Type Size
1 form4-02132015_020209.html 4  
1 form4-02132015_020209.xml 4 7616
  Complete submission text file 0001415889-15-000537.txt   8996
Mailing Address 11085 TORREYANA ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SUITE 100 SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONYX PHARMACEUTICALS, INC. 2100 POWELL STREET EMERYVILLE CA 94608
Business Address
Brege Laura (Reporting) CIK: 0001365619 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 15616720